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In the paper entitled Myocardial ischemia in the absence of obstructive coronary lesion: the role of poststress diastolic dysfunction in detecting early coronary atherosclerosis, Gimelli et al evaluated the interactions between non-obstructive coronary atherosclerosis on invasive coronary angiography (ICA) and myocardial perfusion imaging (MPI) with a cadmium-zinc-telluride (CZT) camera. 1 They calculated the summed stress score (SSS) for perfusion, left ventricular ejection fraction (LVEF) for global systolic function, and peak filling rate (PFR) for global diastolic function. This preliminary paper concludes that in patients with chest pain, despite the absence of anatomically obstructive coronary artery disease (CAD), the alteration of post-stress left ventricular diastolic function associates with the presence of non-obstructive atherosclerosis on ICA. In these subjects, the degree of post-stress left ventricular diastolic impairment correlates with myocardial perfusion abnormalities on MPI, despite the absence of a relevant reduction in post-stress LVEF. The authors suggest that a combined evaluation of myocardial perfusion and diastolic function may better detect the presence of early stages of CAD. This paper and its conclusions lead us to ask three key questions:
-Is the detection of non-obstructive CAD helpful? -Is post-stress diastolic dysfunction an adequate marker? -Is MPI able to detect post-stress diastolic dysfunction and, thus, non-obstructive CAD?
DETECTION OF NON-OBSTRUCTIVE CAD
CAD remains one of the major causes of mortality. Classically, it has been acknowledged that stress coronary flow decreases significantly only when narrowing exceeds 70%. 2 Stenoses with less than 50% narrowing were supposed not to affect coronary flow reserve and stress myocardial perfusion abnormalities were therefore generally considered to be false-positive findings. More recently, fractional flow reserve (FFR) obtained by pressure wire with ICA has shown a poor correlation between artery narrowing and loss of pressure. Thus, FFR is abnormal (\0.80) in 35% of patients with stenosis between 50% and 70% narrowing. 3 FFR may also be abnormal in patients with stenosis having less than 50% narrowing. 4, 5 Vasospastic angina may occur in patients with non-obstructive atherosclerosis. While it usually happens at rest and only occasionally with exertion in patients with obstructive atherosclerosis, exercise-induced spastic angina is more often observed in patients with non-obstructive atherosclerosis. 6 Moreover, acute coronary syndromes (ACS) are often due to non-obstructive and non-calcified atherosclerotic plaques. Indeed, obstructive stenoses are more often fibrotic and poorly cellular, with thick, fibrous caps. In contrast, culprit lesions in ACS show the rupture of a thin fibrous cap, with exposure towards the lumen of large, soft, prothrombotic, necrotic core material that can trigger occlusive or non-occlusive thrombosis.
seems to be common in non-obstructive CAD and may also be considered. 9 Endothelial dysfunction results in a lack of response to factors of arterial dilatation, especially nitric oxide (NO). Microvascular dysfunction (endothelial independent) is related to impaired smooth muscle relaxation and results in decreased coronary flow reserve. Both are associated with a higher rate of cardiac events. [10] [11] [12] In hypertensive post-menopausal women, the restoration of endothelial function was associated with improved outcome. 13 Statins and ACE inhibitors improve endothelial dysfunction and may benefit patients with non-obstructive CAD. Coronary reactivity dysfunction induces a reduced coronary flow reserve, which may cause later interstitial fibrosis, resulting in impaired diastolic function.
14 For all of these reasons, the identification of non-obstructive atheroma should be considered, even if the clinical implication remains unclear. The most common method for diagnosing subclinical CAD is measurement of a coronary artery calcium score (CACS). 15 Until now, MPI was used to assess the functional consequences of obstructive CAD and showed no perfusion or systolic function abnormalities in nonobstructive CAD. Patients without known CAD undergoing stress MPI could undergo a same-setting coronary calcification study. 16 However, CACS underestimates the presence of an atherosclerotic plaque burden, ignoring soft, non-calcified plaques. But coronary artery CT angiography may show non-calcified, non-obstructive coronary stenosis, even if it fails to quantify it accurately.
POST-STRESS DIASTOLIC DYSFUNCTION
Diastolic dysfunction (DD) results in ineffective left atrial emptying and left ventricular filling, reduces the ability to augment cardiac output with exercise, increases pulmonary pressure, and results in symptoms and fluid retention. Diastolic relaxation and filling appear to be altered by ischemia, which lead to asynchronous myocardial relaxation and, thus, global DD. The pathophysiology of systolic and diastolic dysfunction is quite different: while systolic dysfunction seems to be a disease of calcium handling, DD seems to be an increased myofilament sensitivity to calcium. 17 Diastolic function seems more susceptible to ischemia than systolic function. Therefore, DD precedes the onset of systolic dysfunction and takes longer to resolve. 18 In ACS, DD assessed by MRI remains 24 hours after reflow in regions underperfused during coronary occlusion and in the absence of infarct, whereas regional systolic contractility has recovered. DD is more marked when microvascular obstruction is present at the tissue level after reopening of the coronary artery. 19 DD is also impaired in stable obstructive CAD. Increased left ventricular end-diastolic pressure (LVEDP) measured by left cardiac catheterization is correlated with the severity and the extent of obstructive CAD, evaluated by invasive coronary angiography (ICA). 20 Non-obstructive CAD can also result in DD: non-obstructive CAD assessed by computed tomography coronary angiography (CTCA) is associated with increased left ventricular pressure (LVFP) measured by echography; 21 in patients without ischemia, an abnormal coronary calcium score in the absence of ischemia is associated with echographic parameters of DD. 22 In women with signs and symptoms of ischemia in the absence of obstructive CAD, DD was observed with cardiac MRI. 8 Thus, diastolic function is impaired both in obstructive CAD, correlated with the extent and severity of obstructive disease, and in non-obstructive CAD. However, DD is not specific to obstructive or non-obstructive CAD. Preclinical diastolic dysfunction (PDD), i.e., DD with normal systolic function and no symptoms of heart failure, is prevalent in the general adult population (approximately 20% to 30%, increasing with age, hypertension, and diabetes), but remains poorly understood. 17 Available data suggest that patients with PDD are diverse. DD is known to be associated with left ventricular hypertrophy (LVH), but recent investigations suggest that DD precedes the development of LVH. Moreover, regression of LVH with antihypertensive treatment results in little change in DD parameters. 17 Despite the fact that DD is considered the first stage of diastolic disease with natural progression to heart failure with preserved ejection fraction (HFpEF), 8, 14, 17 inconsistent features may be pointed out: PDD is associated with cardiovascular risk factors, such as hyperlipidemia, diabetes, and hypertension, but also with peripheral vascular disease; conversely, non-cardiac risk factors, such as renal impairment, pulmonary airflow limitations, or anemia, are involved in the progression of DD to HFpEF; therapeutic strategies focusing on cardiovascular risk factors and comorbidities have not been shown to be effective in improving outcome in HFpEF. 17 One might therefore wonder whether DD with ischemia in the absence of obstructive CAD is the early stage of a diastolic function disease which will progress to HFpEF or whether DD is an independent marker associated with cardiovascular risk factors or peripheral arterial disease.
POST-STRESS DIASTOLIC DYSFUNCTION ASSESSED BY MPI
The concept of stress DD has been introduced with stress echography. MPI has the advantage of acquiring images 10 to 15 minutes after exercise, avoiding an elevated heart rate, which may perturb the evaluation of left ventricular dynamics, thus allowing persistent DD evaluation and lower cardiac rate to be combined. The MPI protocol described for the assessment of diastolic function used a CZT camera (Discovery NM 530c, Ge Healthcare, Haifa, Israel), of which the myocardial count efficiency is sixfold that of a conventional camera.
23 99m Tc-tetrofosmin was injected at stress (185-222 MBq, i.e., 5-6 mCi) then at rest (370-444 MBq, i.e., 10-12 mCi) with a list mode acquisition of 7 minutes and an iterative reconstruction (50 iterations), without scatter or attenuation correction. Left ventricular function analysis was performed from 16-frame reformatted images using commercially available software (Corridor 4DM, Invia, Ann Arbor, Mi, USA). 24 Besides left ventricular end-diastolic volume (EDV), end-systolic volume (ESV), and ejection fraction (EF), the left ventricular volume curve was fitted with a fourth-order harmonic function in order to derive the PFR, expressed in EDV/s as an indicator of left ventricular diastolic function. Measurements were obtained at stress and rest and measures of PFR were corrected for the R-R interval. 25 Characteristics of the studied population (mean age of 69 years, male gender in 65% of cases, hypertension in 57% of cases) avoided major bias, given the prevalence and the polymorphism of DD reported above. At rest, PFR was equal to 2.7 ± 0.8 in normal patients, 2.5 ± 0.7 in non-obstructive CAD, 2.5 ± 0.7 in one-vessel obstructive CAD, and 2.3 ± 0.6 in three-vessel disease. At stress, differences were more marked, with PFR equal to 2.9 ± 0.8 in normal patients, 2.5 ± 0.9 in non-obstructive CAD, 2.5 ± 0.7 in one-vessel obstructive CAD, and 2.1 ± 0.67 in three-vessel disease. 26 These results confirm that post-stress evaluation of diastolic function is more discriminative than rest evaluation. They show that non-obstructive CAD has a profile that differs from that of a normal coronary artery, but is similar to that of single-vessel obstructive CAD. Additionally, the accuracy of these results illustrates the potential of MPI to assess stress DD. However, the large standard deviations and overlap between normal, non-obstructive CAD, and obstructive CAD limit the information that could be utilized for a given patient. With a stress PFR cutoff of 2.0, only 28% of non-obstructive CAD cases are detected and 13% of normal patients are over-diagnosed. However, it is strongly suggested that stress DD could be an additional tool for more complete characterization of CAD. Therefore, MPI might give, at the same time, incremental information about perfusion and systolic and diastolic function.
CLINICAL IMPLICATIONS
Due to the preliminary character and limitations of the aforementioned study, particularly the overlap between patients with non-obstructive CAD and those without CAD, further studies are needed. At this point in time, stress DD is an interesting pathophysiological concept, but does not provide diagnostic support. Up to now, clinical implications remain unclear; however, several options may be suggested: The assessment of diastolic function with MPI in the routine clinical setting would provide additional data when obstructive CAD is present and could suggest the existence of non-obstructive CAD when no ischemia or mild ischemia is detected. It would also be worthwhile to study the added value of combined CACS. On the other hand, the association of MPI and CTA would give additional information about coronary anatomy, myocardial perfusion, and systolic and diastolic function. The challenge could be to identify high-risk subnormal patients. For example, we could ask if the outcome would be the same in patients with non-calcified and non-obstructive stenosis, with or without stress DD in MPI.
